STOCK TITAN

NEOG director reports RSU vesting and 1,777-share settlement

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Neogen Corp (NEOG) reported a director’s equity transaction. On 10/27/2025, 1,777 restricted stock units (RSUs) vested and were settled into an equal number of common shares via transaction code M. The non-derivative table shows 1,777 shares acquired at a listed price of $6.19. Following the transaction, the reporting person beneficially owned 96,347 shares directly. Remarks confirm each RSU equals one share and that the RSUs vested and were settled on the same date.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BOREL JAMES C

(Last) (First) (Middle)
620 LESHER PLACE

(Street)
LANSING MI 48912

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/27/2025 M 1,777 A $6.19 96,347 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $6.19 10/27/2025 M 1,777 10/27/2025 10/27/2025 Common Stock 1,777 $6.19 1,777 D
Explanation of Responses:
Remarks:
Each RSU is the economic equivalent of one share of common stock. On October 27, 2025, these RSUs vested and were settled for an equal number of shares of common stock.
Christopher Sefcheck (Attorney in Fact) 10/29/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Neogen (NEOG) disclose in this Form 4?

A director reported RSUs vesting and settlement into 1,777 common shares on 10/27/2025 via code M.

How many shares did the director acquire, and at what price?

The director acquired 1,777 common shares at a listed price of $6.19 per share.

What derivative securities were involved in the NEOG filing?

Restricted Stock Units (RSUs) totaling 1,777, each equivalent to one share, vested and were settled on 10/27/2025.

What is the reporting person’s ownership after the transaction?

The reporting person beneficially owned 96,347 shares directly after the reported transaction.

What was the Form 4 transaction code and what does it indicate?

Transaction code M indicates a conversion of derivative securities (RSUs) into common stock.

What is the relationship of the reporting person to Neogen (NEOG)?

The reporting person is a Director of Neogen Corp.
Neogen Corp

NASDAQ:NEOG

NEOG Rankings

NEOG Latest News

NEOG Latest SEC Filings

NEOG Stock Data

1.56B
215.36M
0.85%
112.78%
8.46%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
LANSING